A TNT-1 F(ab′)2 conjugate with interleukin 2 led to the greatest enhancement in the tumor uptake of 125I-TNT-1 (Fab′), with a 275% increase in tumor radioactivity 3 days after administration45. The gene discussed is IL2; the disease is neoplasm.